{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:28:59Z","timestamp":1772627339327,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,2,10]],"date-time":"2009-02-10T00:00:00Z","timestamp":1234224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s11882-009-0023-4","type":"journal-article","created":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T11:47:25Z","timestamp":1234180045000},"page":"155-163","source":"Crossref","is-referenced-by-count":69,"title":["Aspirin sensitivity and desensitization for asthma and sinusitis"],"prefix":"10.1007","volume":"9","author":[{"given":"Donald D.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,10]]},"reference":[{"key":"23_CR1","first-page":"189","volume":"30","author":"M.F. Widal","year":"1922","unstructured":"Widal MF, Abrami P, Lermeyez J: Idiosyncratic anaphylaxis [in French]. Presse Med 1922, 30:189\u2013192.","journal-title":"Presse Med"},{"key":"23_CR2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","volume":"68","author":"M. Samter","year":"1968","unstructured":"Samter M, Beers R Jr: Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968, 68:975\u2013983.","journal-title":"Ann Intern Med"},{"key":"23_CR3","first-page":"1695","volume-title":"Middleton\u2019s Allergy Principles and Practice","author":"D. Stevenson","year":"2003","unstructured":"Stevenson D, Simon RR, Zuraw BL: Sensitivity to aspirin and NSAIDs. In Middleton\u2019s Allergy Principles and Practice, edn 6. Edited by Adkinson NJ, Yunginger JW, Busse WW, et al. Philadelphia: CV Mosby and Co.; 2003:1695\u20131710.","edition":"edn 6"},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","volume":"113","author":"S. Johannessen","year":"2004","unstructured":"Johannessen S, Bieber T, Dahl R, et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832\u2013836.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","volume":"118","author":"D. Stevenson","year":"2006","unstructured":"Stevenson D, Szczeklik A: Current and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006, 118:773\u2013786.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","volume":"89","author":"M. Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno M, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002, 89:474\u2013478.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","volume":"16","author":"A. Szczeklik","year":"2000","unstructured":"Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000, 16:432\u2013436.","journal-title":"Eur Respir J"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","volume":"328","author":"C. Jenkins","year":"2004","unstructured":"Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin-induced asthma and its implications for clinical practice. BMJ 2004, 328:434\u2013437.","journal-title":"BMJ"},{"key":"23_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2222.1976.tb01896.x","volume":"6","author":"J.C. Delaney","year":"1976","unstructured":"Delaney JC: The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976, 6:177\u2013181.","journal-title":"Clin Allergy"},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","volume":"100","author":"A.B. Dursun","year":"2008","unstructured":"Dursun AB, Woessner KA, Simon RA, et al.: Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps and chronic sinusitis. Ann Allergy Asthma Immunol 2008, 100:420\u2013425.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0091-6749(79)90080-0","volume":"64","author":"R.W. Weber","year":"1979","unstructured":"Weber RW, Hoffman M, Raine DA, Nelson HS: Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol 1979, 64:32\u201337.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","volume":"60","author":"A. Szczeklik","year":"1977","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977, 60:276\u2013284.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","volume":"84","author":"R.A. Settipane","year":"1989","unstructured":"Settipane RA, Stevenson DD: Cross sensitivity with acetaminophen in aspirin sensitive asthmatics. J Allergy Clin Immunol 1989, 84:26\u201333.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0091-6749(05)80179-4","volume":"86","author":"D.D. Stevenson","year":"1990","unstructured":"Stevenson DD, Hougham A, Schrank P, et al.: Disalcid cross-sensitivity in aspirin sensitive asthmatics. J Allergy Clin Immunol 1990, 86:749\u2013758.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02770909909055417","volume":"36","author":"S. Bavbek","year":"1999","unstructured":"Bavbek S, Celik G, Ediger D, et al.: The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. J Asthma 1999, 36:657\u2013663.","journal-title":"J Asthma"},{"key":"23_CR16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/ajrccm.157.3.9608004","volume":"157","author":"A. Vaghi","year":"1998","unstructured":"Vaghi A: Tolerance of meloxicam in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1998, 157:715.","journal-title":"Am J Respir Crit Care Med"},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1067\/mai.2003.1450","volume":"111","author":"P. Gyllfors","year":"2003","unstructured":"Gyllfors P, Bochenek G, Overholt J, et al.: Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003, 111:1116\u20131121.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mai.2001.116290","volume":"108","author":"D. Stevenson","year":"2001","unstructured":"Stevenson D, Simon RA: Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J Allergy Clin Immunol 2001, 108:47\u201351.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2222.2001.01075.x","volume":"31","author":"A. Szczeklik","year":"2001","unstructured":"Szczeklik A, Nizankowska E, Bochenek G, et al.: Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001, 31:219\u2013225.","journal-title":"Clin Exp Allergy"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.10426","volume":"46","author":"K. Woessner","year":"2002","unstructured":"Woessner K, Simon RA, Stevenson DD: The safety of celecoxib in aspirin exacerbated respiratory disease. Arthritis Rheum 2002, 46:2201\u20132206.","journal-title":"Arthritis Rheum"},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1081-1206(10)62327-7","volume":"87","author":"M.B. Levy","year":"2001","unstructured":"Levy MB, Fink JN: Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001, 87:72\u201373.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2005.10.021","volume":"117","author":"S. Baldassarre","year":"2006","unstructured":"Baldassarre S, Schandene L, Choufani G, Michils A: Asthma attacks induced by low doses of celecoxib, aspirin and acetaminophen. J Allergy Clin Immunol 2006, 117:215\u2013217.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR23","first-page":"745","volume":"21","author":"D.D. Stevenson","year":"2001","unstructured":"Stevenson DD: Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 2001, 21:745\u2013768.","journal-title":"Immunol Allergy Clin North Am"},{"key":"23_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2500\/108854188778995020","volume":"9","author":"D.D. Stevenson","year":"1988","unstructured":"Stevenson DD: Oral challenges to detect aspirin and sulfite sensitivity in asthma. N Engl Reg Allergy Proc 1988, 9:135\u2013142.","journal-title":"N Engl Reg Allergy Proc"},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1034\/j.1399-3003.2000.15e09.x","volume":"15","author":"E. Nizankowska","year":"2000","unstructured":"Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A: Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000, 15:863\u2013869.","journal-title":"Eur Respir J"},{"key":"23_CR26","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.rmed.2006.03.017","volume":"100","author":"C. Micheletto","year":"2006","unstructured":"Micheletto C, Tognella S, Visconti M, et al.: Changes in urinary LTE4 and nasal function following nasal provocation tests with ASA-tolerant and intolerant asthmatics. Respir Med 2006, 100:2144\u20132150.","journal-title":"Respir Med"},{"key":"23_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0091-6749(98)70163-0","volume":"101","author":"M. Milewski","year":"1998","unstructured":"Milewski M, Mastalerz L, Nizankowska E, Szczeklik A: Nasal provocation test with lysine-aspirin for diagnosis of aspirinsensitive asthma. J Allergy Clin Immunol 1998, 101:581\u2013586.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","volume":"32","author":"M.P. Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD: The effect of leukotriene modifier drugs on ASA-induced asthma and rhinitis reactions. Clin Exp Allergy 2002, 32:1491\u20131496.","journal-title":"Clin Exp Allergy"},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","volume":"97","author":"A. White","year":"2006","unstructured":"White A, Ludington E, Mehra P, et al.: Effect of leukotriene modifier drugs on the safety of OACs. Ann Allergy Asthma Immunol 2006, 97:688\u2013693.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"23_CR30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60012-9","volume":"97","author":"A. White","year":"2006","unstructured":"White A, Bigby TA, Stevenson DD: Intranasal ketorolac challenge for the diagnosis of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2006, 97:190\u2013195.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"23_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2007.03.020","volume":"120","author":"A. Williams","year":"2007","unstructured":"Williams A, Simon RA, Woessner KM, Stevenson DD: The relationship between historical aspirin-induced asthma and the severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol 2007, 120:273\u2013277.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2222.1988.tb02838.x","volume":"18","author":"A. Szczeklik","year":"1988","unstructured":"Szczeklik A: Aspirin-induced asthma as a viral disease. Clin Allergy 1988, 18:15\u201320.","journal-title":"Clin Allergy"},{"key":"23_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaci.2008.03.028","volume":"122","author":"F. Davoine","year":"2008","unstructured":"Davoine F, Cao M, Wu Y, et al.: Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. J Allergy Clin Immunol 2008, 122:69\u201377.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","volume":"104","author":"P. Daffern","year":"1999","unstructured":"Daffern P, Muilenburg D, Hugli TE, et al.: Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999, 104:559\u2013564.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR35","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","volume":"154","author":"A. Szczeklik","year":"1996","unstructured":"Szczeklik A, Sladek K, Dworski R, et al.: Bronchial aspirin challenge causes specific eicosanoid response in aspirinsensitive asthmatics. Am J Respir Crit Care Med 1996, 154:1608\u20131614.","journal-title":"Am J Respir Crit Care Med"},{"key":"23_CR36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mai.2001.112853","volume":"107","author":"M. Sanak","year":"2001","unstructured":"Sanak M, Szczeklik A: Leukotriene C4 synthase polymorphism and aspirin-induced asthma. J Allergy Clin Immunol 2001, 107:561\u2013562.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR37","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa013508","volume":"347","author":"A. Sousa","year":"2002","unstructured":"Sousa A, Parikh A, Scadding G, et al.: Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002, 347:1524\u20131526.","journal-title":"N Engl J Med"},{"key":"23_CR38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","volume":"111","author":"G. Bochenek","year":"2003","unstructured":"Bochenek G, Nagraba K, Nizankowska E, Szczeklik A: A controlled study of 9alpha11beta-PGF2 (a PGD2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenges. J Allergy Clin Immunol 2003, 111:743\u2013749.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0952-3278(03)00079-6","volume":"69","author":"W. Powell","year":"2003","unstructured":"Powell W: A novel PGD2 receptor expressed in eosinophils. Prostaglandins Leukot Essent Fatty Acids 2003, 69:179\u2013185.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"23_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.053","volume":"533","author":"A. Szczeklik","year":"2006","unstructured":"Szczeklik A, Sanak M: The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006, 533:145\u2013155.","journal-title":"Eur J Pharmacol"},{"key":"23_CR41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0091-6749(93)90264-G","volume":"91","author":"M.L. Kowalski","year":"1993","unstructured":"Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, et al.: Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 1993, 91:580\u2013598.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR42","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)90799-8","volume":"345","author":"A. Szczeklik","year":"1995","unstructured":"Szczeklik A: Prostaglandin E2 and aspirin-induced asthma [letter, comment]. Lancet 1995, 345:1056.","journal-title":"Lancet"},{"key":"23_CR43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","volume":"153","author":"P. Sestini","year":"1996","unstructured":"Sestini P, Armetti L, Gambaro G, et al.: Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996, 153:572\u2013575.","journal-title":"Am J Respir Crit Care Med"},{"key":"23_CR44","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","volume":"157","author":"B. Dahlen","year":"1998","unstructured":"Dahlen B, Nizankowska E, Szczeklik A, et al.: The benefits of adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Resp Crit Care Med 1998, 157:1187\u20131194.","journal-title":"Am J Resp Crit Care Med"},{"key":"23_CR45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.165.1.2010080","volume":"165","author":"S. Dahlen","year":"2002","unstructured":"Dahlen S, Malstrom K, Nizankowska E, et al.: Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist. A randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002, 165:9\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"23_CR46","first-page":"7","volume":"29","author":"Y.G. Amar","year":"2000","unstructured":"Amar YG, Frenkiel S, Sobol SE: Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter\u2019s triad. J Otolaryngol 2000, 29:7\u201312.","journal-title":"J Otolaryngol"},{"key":"23_CR47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","volume":"86","author":"J.A. Sweet","year":"1990","unstructured":"Sweet JA, Stevenson DD, Simon RA, Mathison DA: Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J Allergy Clin Immunol 1990, 86:59\u201365.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","volume":"111","author":"M. Berges-Gimeno","year":"2003","unstructured":"Berges-Gimeno M, Simon RA, Stevenson DD: Treatment with aspirin desensitization in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol 2003, 111:180\u2013186.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","volume":"98","author":"D.D. Stevenson","year":"1996","unstructured":"Stevenson DD, Hankammer MA, Mathison DA, et al.: Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J Allergy Clin Immunol 1996, 98:751\u2013758.","journal-title":"J Allergy Clin Immunol"},{"key":"23_CR50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2006.06.019","volume":"116","author":"D. Stevenson","year":"2006","unstructured":"Stevenson D, Simon RA: Selection of patients for aspirin desensitization. J Allergy Clin Immunol 2006, 116:801\u2013804.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-009-0023-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-009-0023-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-009-0023-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:42:20Z","timestamp":1559432540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-009-0023-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,10]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s11882-009-0023-4","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,10]]}}}